Zacks Investment Research Lowers Orthopediatrics (KIDS) to Sell

Zacks Investment Research downgraded shares of Orthopediatrics (NASDAQ:KIDS) from a hold rating to a sell rating in a report released on Tuesday.

According to Zacks, “OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. “

Several other research firms have also recently issued reports on KIDS. Stifel Nicolaus initiated coverage on Orthopediatrics in a research report on Monday, November 6th. They issued a buy rating and a $23.00 price objective for the company. BTIG Research reiterated a buy rating and issued a $24.00 price objective on shares of Orthopediatrics in a research report on Friday, January 5th. William Blair initiated coverage on Orthopediatrics in a research report on Monday, November 6th. They issued an outperform rating for the company. Finally, Piper Jaffray Companies initiated coverage on Orthopediatrics in a research report on Monday, November 6th. They issued an overweight rating and a $24.00 price objective for the company. Two research analysts have rated the stock with a sell rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of $23.67.

Orthopediatrics (NASDAQ KIDS) traded down $0.06 during trading hours on Tuesday, reaching $19.10. The company’s stock had a trading volume of 15,316 shares, compared to its average volume of 45,989. The stock has a market capitalization of $244.60 and a PE ratio of 19.90. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00. Orthopediatrics has a 1 year low of $17.03 and a 1 year high of $23.00.

In other news, Director Harold Ruf purchased 11,500 shares of the company’s stock in a transaction dated Monday, October 16th. The stock was acquired at an average price of $13.00 per share, for a total transaction of $149,500.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

TRADEMARK VIOLATION WARNING: This piece was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://ledgergazette.com/2018/01/12/zacks-investment-research-lowers-orthopediatrics-kids-to-sell.html.

Orthopediatrics Company Profile

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Get a free copy of the Zacks research report on Orthopediatrics (KIDS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply